Synthesis, antimalarial activity, and structure-activity relationship of 7-(2-Phenoxyethoxy)-4(1H)-quinolones

Journal of Medicinal Chemistry

Volumn 54, Issue 24, 2011, Pages 8321-8327

  Cross, R Matthew ^a   Namelikonda, Niranjan K ^a   Mutka, Tina S ^b   Luong, Lisa ^a   Kyle, Dennis E ^b   Manetsch, Roman ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 (2 PHENOXYETHOXY) 4(1H) QUINOLONE; ATOVAQUONE; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; MALARIA; MEDICAL PARAMETERS; PLASMODIUM BERGHEI INFECTION; RESISTANCE INDEX; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

ANIMALS; ANTIMALARIALS; ATOVAQUONE; CELL LINE; DRUG RESISTANCE; MICE; PLASMODIUM FALCIPARUM; QUINOLONES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84055211848     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm200718m     Document Type: Article

References (25)

1. Ryley, J. F.; Peters, W. Antimalarial activity of some quinolone esters. Ann. Trop. Med. Parasitol. 1970, 64, 209-222.
2. Wells, T. N. C.; Alonso, P. L.; Gutteridge, W. E. New medicines to improve control and contribute to the eradication of malaria. Nat. Rev. Drug Discovery 2009, 8, 879-891.
3. World Malaria Report 2009; The World Health Organization: Geneva, Switzerland, 2008; http://www.who.int/whosis/whostat/EN-WHS09-Full.pdf.
4. White, N. J.; Nosten, F.; Looareesuwan, S.; Watkins, W. M.; Marsh, K.; Snow, R. W.; Kokwaro, G.; Ouma, J.; Hien, T. T.; Molyneux, M. E.; Taylor, T. E.; Newbold, C. I.; Ruebush, T. K. 2nd; Danis, M.; Greenwood, B. M.; Anderson, R. M.; Olliaro, P. Averting a malaria disaster. Lancet 1999, 353, 1965-1967.
5. Mazier, D.; Renia, L.; Snounou, G. A pre-emptive strike against malaria's stealthy hepatic forms. Nat. Rev. Drug Discovery 2009, 8, 854-864.
6. Dondorp, A. M.; Nosten, F.; Yi, P.; Das, D.; Phyo, A. P.; Tarning, J.; Lwin, K. M.; Ariey, F.; Hanpithakpong, W.; Lee, S. J.; Ringwald, P.; Silamut, K.; Imwong, M.; Chotivanich, K.; Lim, P.; Herdman, T.; An, S. S.; Yeung, S.; Singhasivanon, P.; Day, N. P. J.; Lindegardh, N.; Socheat, D.; White, N. J. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 2009, 361, 455-467.
7. Vennerstrom, J. L.; Arbe-Barnes, S.; Brun, R.; Charman, S. A.; Chiu, F. C. K.; Chollet, J.; Dong, Y.; Dorn, A.; Hunziker, D.; Matile, H.; McIntosh, K.; Padmanilayam, M.; Santo Tomas, J.; Scheurer, C.; Scorneaux, B.; Tang, Y.; Urwyler, H.; Wittlin, S.; Charman, W. N. Identification of an antimalarial synthetic trioxolane drug development candidate. Nature (London, U. K.) 2004, 430, 900-904.
8. O'Neill, P. M.; Amewu, R. K.; Nixon, G. L.; El Garah, F. B.; Mungthin, M.; Chadwick, J.; Shone, A. E.; Vivas, L.; Lander, H.; Barton, V.; Muangnoicharoen, S.; Bray, P. G.; Davies, J.; Park, B. K.; Wittlin, S.; Brun, R.; Preschel, M.; Zhang, K.; Ward, S. A. Identification of a 1,2,4,5-tetraoxane antimalarial drug-development candidate (RKA 182) with superior properties to the semisynthetic artemisinins. Angew. Chem., Int. Ed. 2010, 49 (5693-5697), S5693/1-S5693/10.
9. Cross, R. M.; Monastyrskyi, A.; Mutka, T. S.; Burrows, J. N.; Kyle, D. E.; Manetsch, R. Endochin optimization: structure-activity and structure-property relationship studies of 3-substituted 2-methyl-4(1H)- quinolones with antimalarial activity. J. Med. Chem. 2010, 53, 7076-7094.
10. Cross, R. M.; Maignan, J. R.; Mutka, T. S.; Luong, L.; Sargent, J.; Kyle, D. E.; Manetsch, R. Optimization of 1,2,3,4-Tetrahydroacri-din-9(10H)-ones as Antimalarials Utilizing Structure-Activity and Structure-Property Relationships. J. Med. Chem. 2011, 54, 4399-4426.
11. Winter, R. W.; Kelly, J. X.; Smilkstein, M. J.; Dodean, R.; Hinrichs, D.; Riscoe, M. K. Antimalarial quinolones: synthesis, potency, and mechanistic studies. Exp. Parasitol. 2008, 118, 487-497.
12. Zhang, Y.; Guiguemde, W. A.; Sigal, M.; Zhu, F.; Connelly, M. C.; Nwaka, S.; Guy, R. K. Synthesis and structure-activity relationships of antimalarial 4-oxo-3-carboxyl quinolones. Bioorg. Med. Chem. 2010, 18, 2756-2766.
13. Puri, S. K.; Dutta, G. P. Quinoline esters as potential antimalarial drugs: effect on relapses of Plasmodium cynomolgi infections in monkeys. Trans. R. Soc. Trop. Med. Hyg. 1990, 84, 759-760.
14. Bowie, R. A.; Grant, M. S.; Jones, W. G. M. 4-Quinolinol-3-carboxylate Coccidiostats. 1966-309741120870, 19660711, 1968.
15. Mizzoni, R. H.; Goble, F.; Konopka, E.; Gelzer, J; Szanto, J.; Maplesden, D. C.; Brown, J. E.; Boxer, J.; Zaunius, G.; Ziegler, J. B.; DeStevens, G. Structure and anticoccidial activity among some 4-hydroxyquinolinecarboxylates. J. Med. Chem. 1970, 13, 870-878.
16. Cross, R. M.; Manetsch, R. Divergent route to access structurally diverse 4-quinolones via mono or sequential cross-couplings. J. Org. Chem. 2010, 75, 8654-8657.
17. Hattori, K.; Sajiki, H.; Hirota, K. Chemoselective control of hydrogenation among aromatic carbonyl and benzyl alcohol derivatives using Pd/C(en) catalyst. Tetrahedron 2001, 57, 4817-4824.
18. Curran, T. T. Gould-Jacobs reaction. Name React. Heterocycl. Chem. 2005, 423-436.
19. Mitscher, L. A. Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents. Chem. Rev. (Washington, DC, U. S.) 2005, 105, 559-592.
20. Huse, H.; Whiteley, M. 4-Quinolones: smart phones of the microbial world. Chem. Rev. (Washington, DC, U. S.) 2011, 111, 152-159.
21. Reid, C. S.; Patrick, D. A.; He, S.; Fotie, J.; Premalatha, K.; Tidwell, R. R.; Wang, M. Z.; Liu, Q.; Gershkovich, P.; Wasan, K. M.; Wenzler, T.; Brun, R.; Werbovetz, K. A. Synthesis and antitrypano-somal evaluation of derivatives of N-benzyl-1,2-dihydroquinolin-6-ols: effect of core substitutions and salt formation. Bioorg. Med. Chem. 2011, 19, 513-523.
22. Kawasaki, I.; Matsuda, K.; Kaneko, T. Preparation of 1,7-bis-(p- hydroxyphenyl)heptane. Bull. Chem. Soc. Jap. 1971, 44, 1986-1987.
23. Desjardins, R. E.; Canfield, C. J.; Haynes, J. D.; Chulay, J. D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 1979, 16, 710-718.
24. Looareesuwan, S.; Viravan, C.; Webster, H. K.; Kyle, D. E.; Hutchinson, D. B.; Canfield, C. J. Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am. J. Trop. Med. Hyg. 1996, 54, 62-66.
25. Milhous, W. K.; Gerena, L.; Kyle, D. E.; Oduola, A. M. J. In vitro strategies for circumventing antimalarial drug resistance. Prog. Clin. Biol. Res. 1989, 313, 61-72.